Johanna Mercier - Mar 10, 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Commercial Officer
Signature: /s/ Edward S. Son by Power of Attorney for Johanna Mercier
Stock symbol: GILD
Transactions as of: Mar 10, 2025
Transactions value $: -$457,939
Form type: 4
Date filed: 3/12/2025, 07:15 PM
Previous filing: Feb 6, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+8.08K	+6.73%		128K	Mar 10, 2025	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$458K	-3.91K	-3.05%	$117.21	124K	Mar 10, 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-8.08K	-22.32%		28.1K	Mar 10, 2025	Common Stock	8.08K		Direct	F1, F2
transaction	GILD	Non-qualified Stock Option (Right to Buy)	Award	$0	+49K		$0.00	49K	Mar 10, 2025	Common Stock	49K	$117.21	Direct	F3
transaction	GILD	Restricted Stock Unit	Award		+11.1K	+39.45%		39.2K	Mar 10, 2025	Common Stock	11.1K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3	The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.